Stock Research for BRSYF

BRSYF

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

BRSYF Stock Chart & Research Data

The BRSYF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BRSYF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


BRSYF Due diligence Resources & Stock Charts

The BRSYF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View BRSYF Detailed Price Forecast - CNN Money CNN View BRSYF Detailed Summary - Google Finance
Yahoo View BRSYF Detailed Summary - Yahoo! Finance Zacks View BRSYF Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View BRSYF Trends & Analysis - Trade-Ideas Barrons View BRSYF Major Holders - Barrons
NASDAQ View BRSYF Call Transcripts - NASDAQ Seeking View BRSYF Breaking News & Analysis - Seeking Alpha
Spotlight View BRSYF Annual Report - CompanySpotlight.com OTC Report View BRSYF OTC Short Report - OTCShortReport.com
TradeKing View BRSYF Fundamentals - TradeKing Charts View BRSYF SEC Filings - Bar Chart
WSJ View Historical Prices for BRSYF - The WSJ Morningstar View Performance/Total Return for BRSYF - Morningstar
MarketWatch View the Analyst Estimates for BRSYF - MarketWatch CNBC View the Earnings History for BRSYF - CNBC
StockMarketWatch View the BRSYF Earnings - StockMarketWatch MacroAxis View BRSYF Buy or Sell Recommendations - MacroAxis
Bullish View the BRSYF Bullish Patterns - American Bulls Short Pains View BRSYF Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View BRSYF Stock Mentions - StockTwits PennyStocks View BRSYF Stock Mentions - PennyStockTweets
Twitter View BRSYF Stock Mentions - Twitter Invest Hub View BRSYF Investment Forum News - Investor Hub
Yahoo View BRSYF Stock Mentions - Yahoo! Message Board Seeking Alpha View BRSYF Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for BRSYF - SECform4.com Insider Cow View Insider Transactions for BRSYF - Insider Cow
CNBC View BRSYF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for BRSYF - OTC Markets
Yahoo View Insider Transactions for BRSYF - Yahoo! Finance NASDAQ View Institutional Holdings for BRSYF - NASDAQ


Stock Charts

FinViz View BRSYF Stock Insight & Charts - FinViz.com StockCharts View BRSYF Investment Charts - StockCharts.com
BarChart View BRSYF Stock Overview & Charts - BarChart Trading View View BRSYF User Generated Charts - Trading View




Latest Financial News for BRSYF


BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights
Posted on Wednesday May 08, 2024

Generated Significant 37% Year-over-Year Revenue Growth in Q1 2024 Recorded Positive Quarterly Net Income for Second Consecutive Quarter, and Positive Adjusted EBITDA and Cash Flow from Operations for Third Consecutive Quarter Conference Call to be Held Today at 8:30 AM ET BURLINGTON, Mass. and JERUSALEM, May 08, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported f


BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024
Posted on Wednesday April 24, 2024

BURLINGTON, Mass. and JERUSALEM, April 24, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will report its first quarter 2024 financial results as well as operational highlights before the open of the U.S. financial markets on Wednesday, May 8, 2024. The Company will host a conference call and webcast at 8:30 AM Eastern Time to dis


BrainsWay Expands Deep TMS™ Access in Israel Following Significant Increase in Reimbursement Rates
Posted on Wednesday April 17, 2024

Company Announces 11th Recent System Installed in Israel, with More Expected this YearBURLINGTON, Mass. and JERUSALEM, April 17, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the further expansion of access to its Deep TMS™ treatment in Israel. BrainsWay has steadily increased its presence in the country with 11 recent system installatio


BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson's Disease
Posted on Thursday April 04, 2024

Clinical Data from Multiple Trials Showed Improvements in Both Motor and Non-Motor SymptomsJERUSALEM and BURLINGTON, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced results published in a review article exploring the potential efficacy of Deep Transcranial Magnetic Stimulation (Deep TMS™) as a novel therapeutic approach for Park


Stock Market & Investing Books

Enter a stock symbol to view the stock details.